Nextcure, Inc.
Clinical trials sponsored by Nextcure, Inc., explained in plain language.
-
New drug SIM0505 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug, SIM0505, in about 414 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must have tried at le…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New drug LNCB74 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental drug called LNCB74 in people with advanced solid tumors (cancers that have spread and are hard to treat), including ovarian, breast, endometrial, bile duct, and lung cancers. The main goals are to find a safe dose and see if the drug s…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jun 01, 2026 17:58 UTC